From Medscape Diabetes & Endocrinology

Coverage from the

American Thyroid Association (ATA) 87th Annual Meeting

October 18 - 22, 2017; Victoria, British Columbia

October 18 - 22, 2017 Victoria, British Columbia

ATA Updated Gene-Classifier Test Pinpoints Benign Thyroid Nodules The latest version of the ThyroSeq gene-classifier test showed high negative predictive value in the classification of indeterminate thyroid nodules in a blinded, multicenter study.
Medscape Medical News, October 30, 2017
ATA TERT, BRAF Mutations Mean Poor Papillary Thyroid Cancer Outcomes The combination of TERT and BRAF mutations shows an association with worse outcomes in papillary thyroid cancer, but only in patients over age 45.
Medscape Medical News, October 27, 2017
ATA RAI-Associated Thyroid Antibodies Link to Neonatal Hyperthyroidism Elevated maternal TSH-receptor antibodies in the third trimester following radioiodine treatment for Graves' disease are associated with an increased risk of hyperthyroidism in newborns.
Medscape Medical News, October 25, 2017

Conference News

ATA Updated Gene-Classifier Test Pinpoints Benign Thyroid Nodules
Medscape Medical News, October 30, 2017
ATA TERT, BRAF Mutations Mean Poor Papillary Thyroid Cancer Outcomes
Medscape Medical News, October 27, 2017
ATA RAI-Associated Thyroid Antibodies Link to Neonatal Hyperthyroidism
Medscape Medical News, October 25, 2017
ATA Levothyroxine Dose Tweaks Don't Alter Symptoms in Hypothyroidism
Medscape Medical News, October 25, 2017

ATA Long-term, Low-Dose Methimazole Reduces Hyperthyroidism Relapses
Medscape Medical News, October 24, 2017
ATA Mycophenolate Add-On Improves Graves' Orbitopathy
Medscape Medical News, October 23, 2017
ATA Hypothyroidism Related to Cancer Treatment Linked to Increased Survival
Medscape Medical News, October 20, 2017

Popular News from ATA 2016

Congenital Hypothyroidism Diagnosis Often Delayed Described as an "endocrine emergency," new data show that the diagnosis and subsequent treatment of congenital hypothyroidism -- previously known as cretinism -- is often delayed, even in the US.

Medscape Medical News, Sep 26, 2016
Long-term Results Support Low-Dose Radioiodine Efficacy for DTC The long-term results from the ESTIMABL 1 trial show that a low-dose radioiodine approach in low-risk thyroid cancer is effective at a mean follow-up of just over 5 years.

Medscape Medical News, Sep 28, 2016
TPO-Antibody Positivity Often Falls Below Assay Cutoffs in Pregnancy The findings could have important implications in determining thyroid treatment in pregnancy.
Medscape Medical News, Sep 29, 2016

Medscape Diabetes© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Previous Coverage

ATA 2016: American Thyroid Association